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Abstract 
Background/Purpose: There is a continued need to identify biomarkers for sepsis and organ 
damage in patients with acute cholangitis. We investigated the usefulness of procalcitonin (PCT) as a 
biomarker of inflammation based on Tokyo Guidelines 2013 (TG13). 
Methods:  110 patients treated for acute cholangitis were categorized based on TG13, and levels of 
PCT and common laboratory inflammatory markers were measured. Positive-hemoculture cases 
(n=72) assessed at the time of diagnosis were also correlated with PCT levels.  
Results: PCT and C-reactive protein levels were significantly higher in grade III cases versus grade I. 
Mean PCT levels for positive hemoculture cases (8.6 ng/mL) were significantly higher than those for 
negative cases (0.7 ng/mL). Where hemoculture was found positive or purulent bile was obtained 
from the duodenal papilla, ie, those cases clearly requiring emergency biliary drainage and 
necessitating categorization as grade III, 3 cases were categorized as grade I and 13 as grade II. Only 
PCT showed statistically significant increases in severe cases underestimated as grade I or II despite 
them fundamentally being grade III. 
Conclusions: Acute cholangitis with high PCT levels can signify the need to perform emergency 
biliary drainage and institute intensive care even if categorized by TG13 as not too severe. 
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Introduction  
Acute cholangitis is a clinical condition in which acute inflammation occurs within the bile duct. 
Two factors are involved in this occurrence, namely, the presence of bacteria that have markedly 
proliferated within the bile duct, and the increase in internal pressure within the bile duct, which 
causes the backflow of bacteria or endotoxins within the blood flow. [1.2.3.4.5] Acute cholangitis 
spans various degrees of severity, from minor conditions that improve with conservative medical 
management to severe cases that lead to shock, disturbance of consciousness, etc. [6 ] 
Among these, in cases of severe acute cholangitis, unless the appropriate biliary drainage is 
rapidly performed, a sudden worsening of overall condition follows, often resulting in mortality. 
[7.8.9.10.11.12.13.14.15] Therefore, in order to improve the mortality rate for acute cholangitis, it is 
important to rapidly determine the degree of severity, and take appropriate action. In updated Tokyo 
Guidelines for acute cholangitis and acute cholecystitis (TG13), the diagnostic criteria for acute 
cholangitis and the treatment guidelines by degree of severity are shown, and many clinicians use 
these. [16.17.18] The criteria for determining the degree of severity shown in TG13 are decided 
based on WBC, fever, age, and the presence of jaundice, level of albumin and circulatory impairment, 
disturbance of consciousness, impairment of respiratory function, impairment of renal function, 
hepatic function disorder, and blood coagulopathy. 
In recent years, as a biomarker for sepsis, procalcitonin (PCT) has gained attention with respect to 
various infectious diseases. PCT is a calcitonin precursor with a molecular weight of 13kDa, 
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comprising 116 base amino acids. Usually produced by the C cells of the thyroid gland, it is 
decomposed by a specific enzyme, so the serum PCT value is at or below the measured sensitivity, 
but in a bacterial infection, especially sepsis, it is even produced in cells other than those in the 
thyroid, and it is believed that the serum PCT value rises dramatically. For that reason, it has gained 
attention as a serum marker in the diagnosis of sepsis. [19.20] 
In the present study, we consider the correlation of PCT, which has attracted attention as a 
biomarker of inflammation, with the diagnosis of the degree of severity in acute cholangitis based on 
TG13. 
 
Methods 
The subjects were 110 patients treated for acute cholangitis due to choledocholithiasis from 
January 2010 to December 2013, at Fukuoka University Hospital (Fig. 1). At the time of admission, 
as an indicator of systemic inflammation, body temperature, WBC and CRP were measured; in order 
to assess cholestasis, the presence of jaundice was checked, and alkaline phosphatase (ALP), 
gamma-glutamyl transpeptidase (γ-GTP), aspartate aminotransferase (AST) and alanine 
aminotransferase (ALT) were measured. Moreover, timely abdominal plain X-ray photograph (XP), 
abdominal computed tomography (CT) and magnetic resonance cholangiopancreatography (MRCP) 
were taken, any presence of biliary dilatation, stricture, stone or stent was evaluated, and using TG13, 
diagnosis of acute cholangitis was performed.   
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In addition, an assessment was performed of age, whether or not dopamine was in use during 
treatment, presence of disturbance of consciousness, PaO2/FiO2 rate, serum creatine, international 
normalized ratio of prothrombin time (Pt-INR), platelet count and albumin, and based on TG13, the 
degree of severity was categorized into grade I (mild), grade II (moderate), or grade III (severe) 
groups. At the time of diagnosis, the PCT was simultaneously measured, and its correlation with the 
degree of severity in the Tokyo guideline 2013 (TG13) considered. In addition, taking as subjects the 
72 cases of acute cholangitis attributed to choledocholithiasis for which a hemoculture was 
performed at the time of initial diagnosis, the correlation between the hemoculture at the time of 
acute cholangitis and inflammatory markers was considered. Moreover, an investigation was carried 
out regarding the correlation between inflammatory markers and the findings of purulent infection 
and biliary excretion from the duodenal papilla obtained when ERCP was conducted. 
 
Statistical analysis 
Data are presented as the mean ± standard deviation (SD) or median and interquartile range (IQR). 
Categorical data are presented as number (n) and percentage (%). All statistic assessments are 
two-sided and evaluated at the 0.05 level of significance. Student’s t-test was used for comparisons 
of the mean between the two groups. Some of the data were not normally distributed; therefore, in 
these cases, the nonparametric Mann-Whitney U test was used instead of the t-test. Categorical 
variables were evaluated by Fisher’s exact test. The analysis of variance (ANOVA) was performed to 
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assess the trend of mean stratified according to the Grade scale; the trend test was based on the liner 
contrast. If the non-parametric method was required, then the Jonckheere-Terpstra trend test was 
performed. In addition, for the categorical data, the Cochran-Armitage test was performed. Receiver 
operating characteristic (ROC) curves were used to evaluate the diagnostic value of the markers 
(WBC, CRP, and PCT) for acute cholangitis of grade III and hemoculture positive. All statistical 
analyses were performed using the SPSS 19.0 software package for Windows (SPSS Inc., Chicago, 
IL, USA). 
 
Results 
The relationship informatory biomarkers and the TG13 severity assessment criteria for acute 
cholangitis in all patients 
The disease severity classification of cholangitis in 110 cases suffering from choledocholithiasis 
was as follows: Grade I: 22 cases (20.0%); Grade II: 63 cases (57.3%); and Grade III: 25 cases 
(22.7%). Upon trend testing using a linear comparison by ANOVA, a statistically significant 
declining tendency was observed in the average value of ALB and diastolic blood pressure (DBP) 
along with an increase in Grade (ALB: Grade I, 4.1±0.4; Grade II, 3.5±0.5; Grade III, 3.1±0.7; P < 
0.001. DBP: Grade I, 74±14; Grade II, 71±15; Grade III, 61±11; P = 0.002.). Moreover, according to 
Jonckheere-Tepstra testing, a statistically significant increasing tendency was observed in Age, CRP, 
PCT, Serum total bilirubin level, BUN, Cr, PT-INR, BT, and Pulse along with the increase in Grade 
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(CRP: Grade I, 0.4 [0.2-3.5]; Grade II, 3.6 [1.4-7.1]; Grade III, 5.4 [2.3-12.0]; P < 0.001. PCT: Grade 
I, 0.2 [0.1-0.7]; Grade II, 0.7 0.2-2.7]; Grade III, 6.8 [0.5-48.3]; P < 0.001) (Fig. 2). Further, a 
significant declining tendency was observed in γ-GTP and PLT. At the same time, no significant 
correlation with disease severity classification was observed regarding WBC. Moreover, no 
difference in the gender ratio was observed between Grades (Table 1). 
 From among WBC, CRP, and PCT, PCT showed the highest value regarding the area under the 
curve (AUC), which is an index for predicting Grade III upon ROC analysis (WBC, 0.47 [0.33-0.61]; 
CRP, 0.67 [0.54-0.77]; PCT, 0.75[0.63-0.87]. Fig. 3). Moreover, at this time, the optimal cut-off 
value of CRP and PCT calculated using the Youden Index method was 3.85 and 2.33, respectively, 
and the sensitivity/specificity at this time was: CRP: sensitivity = 0.72, specificity = 0.60; PCT: 
sensitivity = 0.64, specificity = 0.78. 
 
Relation with the result of hemoculture at the time of initial diagnosis 
 From among the 72 cases suffering from choledocholithiasis that underwent a blood culture, 13 
cases (18.1%) were found positive with the culture, while 59 cases (81.9%) were negative. Upon a 
Mann-Whitney’s U-test, it was found that PCT and BT have significantly higher values in the 
positive group compared to the negative group. Moreover, the Grade became significantly higher in 
the positive group. Meanwhile, no significant difference was observed regarding WBC and CRP. 
Moreover, no significant difference was observed regarding age and gender (Table 2). 
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 From among WBC, CRP, and PCT, PCT showed the highest value regarding the AUC, which is an 
index for predicting a result of positive upon ROC analysis (WBC, 0.53 [0.37-0.69]; CRP, 0.48 
[0.31-0.65]; PCT, 0.80[0.69-0.91]. Fig. 4). Moreover, at this time, the optimal cut-off value of PCT 
calculated by the Youden Index method was 1.1, and the sensitivity/specificity at this time was: 
sensitivity = 0.92, specificity = 0.59. 
 
Relationship with the findings of bile juice from the duodenal papilla 
 From among the 72 cases that underwent a blood culture, purulent bile was observed in 24 cases 
(33.3%), with a result of normal yellow in 48 cases (66.7%). Upon a Mann-Whitney's U-test, it was 
found that the PCT, AST, PT-INR, and Pulse had a significantly higher value in the yellow group 
compared to the purulent group. Moreover, the Grade became significantly higher in the purulent 
group. Meanwhile, no significant difference was observed regarding WBC and CRP. Moreover, no 
significant difference was observed regarding age and gender (Table 3). 
 From among WBC, CRP, and PCT, PCT showed the highest value regarding the AUC, which is an 
index for predicting a result of purulent upon ROC analysis (WBC, 0.51 [0.37-0.66]; CRP, 0.46 
[0.32-0.59]; PCT, 0.77[0.64-0.89]. Fig. 5). Moreover, at this time, the optimal cut-off value of PCT 
calculated by the Youden Index method was 3.2, and the sensitivity/specificity at this time was: 
sensitivity = 0.67, specificity = 0.79. 
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Investigation into mild/moderate cases by theTG13 severity assessment criteria for acute 
cholangitis 
 From among the 72 cases that underwent a blood culture, in the 55 cases in which the disease 
severity classification was Grade I or II, 16 cases (29.1%) were of purulent bile or were positive 
upon a blood culture, while 39 cases (70.9%) were yellow and negative. Upon a Mann-Whitney's 
U-test, it was found that only the PCT was significantly higher in the purulent group compared to the 
yellow group (Table 4). 
 From among WBC, CRP, and PCT, PCT showed the highest value regarding the AUC, which is an 
index for predicting a result of purulent bile or positive blood culture upon ROC analysis (WBC, 
0.49 [0.32-0.66]; CRP, 0.50 [0.34-0.65]; PCT, 0.72[0.56-0.88]. Fig. 6). Moreover, at this time, the 
optimal cut-off value of PCT calculated by the Youden Index method was 1.1, and the 
sensitivity/specificity at this time was: sensitivity = 0.69, specificity = 0.77. 
 
Discussion  
Acute cholangitis requires appropriate handling during the acute phase, and with severe acute 
cholangitis, in particular, if appropriate treatment is not performed during the acute phase, it could 
result in mortality. Since the publication of the Tokyo Guidelines for the management of acute 
cholangitis and cholecystitis (TG07), diagnostic criteria and severity assessment criteria for acute 
cholangitis have been presented and extensively used as the primary standard all over the world. 
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However, the sensitivity and specificity of the TG07 diagnostic criteria was insufficient, and the 
severity assessment criteria were not easy to use in the clinical setting. A working team for the 
revision  of the TG07  was  organized,  and  these  criteria  have  been  updated 
through  clinical implementation  and  its  assessment  by means  of a multicenter 
analysis. As a result, the updated TG13 is therefore considered to have a better diagnostic 
capacity than TG07.  
When acute cholangitis becomes severe, the bacteria and endotoxins in the bile migrate, as a result 
of the increase in internal pressure within the bile duct, from the cholangioles to within the blood or 
lymph streams (cholangiovenous and cholangiolymphatic reflux), resulting in organ damage 
throughout the body, such as sepsis or disseminated intravascular coagulation (DIC), etc. Thus, in 
TG13, severe  acute cholangitis (Grade Ⅲ)  is considered to be a state accompanied by full body 
organ damage, such as circulatory impairment, central nervous system damage, impairment of 
respiratory function, impairment of renal function, hepatic function disorder, and blood coagulopathy, 
that are attributed to sepsis. [16]  In addition, an abnormal WBC count, high fever, age, 
hyperbilirubinemia, and hypoalbuminemia were added to the Grade II criteria. 
This updated severity assessment criteria were especially thought to make it possible to accurately 
select the optimal timing to perform biliary drainage for grade II cases at the time of diagnosis 
[1.16.17.18]. However, in our study where hemocultures were found to be positive or purulent bile 
was obtained from the duodenal papilla – in other words, such cases clearly require emergency 
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biliary drainage and should be categorized as Grade Ⅲ cases – 3 cases (5.4%) were categorized as 
Grade I and 13 cases were categorized as Grade II. This result suggests the possibility that the TG13 
diagnostic criteria fail to recognize severe cases that requires emergency biliary drainage by 
underestimating them as Grade I or Grade II cases although fundamentally they should be 
categorized as Grade Ⅲ cases. Therefore, it is considered to be extremely important to identify 
markers that can be easily used to accurately diagnose the presence of sepsis and organ damage in 
acute cholangitis patients. In particular, this study focused on the usefulness of PCT as a biomarker 
of these conditions. 
In recent years, the biological significance of PCT has gradually become clear, and presently, it 
continues to establish its standing as a specific serum marker for bacterial, parasitic and fungal 
infections. The use of PCT can be traced back to the first report, in 1992, by Nylen et al, based on the 
results of the research they conducted on burn patients, of its significance as an inflammation marker 
in severe diseases.[21]  Normally, PCT is synthesized in thyroid gland C cells, as a calcitonin 
precursor. [22]  However, in serious bacterial, parasitic and fungal infections, through the action of 
the infectant or toxin, inflammatory cytokines, such as tumor necrosis factor-α (TNF-α), are 
produced, and with that stimulus, it is reported that PCT is produced across the organs in the body, 
such as the lungs, kidneys, liver, adipose cells and muscles, and then secreted in the blood. On the 
other hand, during a virus infection, inhibition of PCT occurs, owing to interferon-γ. [23] For this 
reason, in non-infectious conditions, virus infections and local bacterial infections not accompanied 
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by systemic symptoms, even if the serum PCT has risen, it remains within the “mild” range. 
Regarding the behavior of PCT, it lags behind the peak of inflammatory cytokines, but from an early 
stage, at approximately 3 hours subsequent to the development of the infection, its blood 
concentration rises, and its presence can be detected earlier than CRP. Subsequently, because its 
half-life is long, at 22 hours, it is easy to maintain its high blood concentration over a long period of 
time. [21] From this characteristic, the measurement of serum PCT has attracted attention as being 
useful in the identification of serious bacterial infections.  
In this study, the usefulness of PCT as an inflammatory marker in categorizing the degree of severity 
in acute cholangitis due to choledocholithiasis, based on TG13, was considered. We established that 
as inflammatory markers, PCT and CRP significantly increased in severe cases. PCT showed the 
highest value regarding the area under the curve (AUC), which is an index for predicting Grade III 
according to a ROC analysis. In addition, in positive hemoculture cases, compared to negative cases, 
it was found that PCT and BT showed a significantly high value. In the same manner, regarding 
cases in which the excretion of purulent bile was confirmed from the duodenal papilla, only the PCT 
was significantly high regarding all inflammatory markers. More importantly, only the PCT results 
showed a statistically significant increase even in those severe cases that were underestimated as 
Grade I or Grade II cases despite the fact that they should have been categorized as Grade Ⅲcases. 
This suggests that PCT, when compared with CRP, increases specifically in bacterial infections, and 
is sensitive at detecting sepsis that is attributed to inflammation of the bile duct. PCT is more specific 
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to bacterial infections, compared with CRP, and this is believed to be attributable to the rise in blood 
concentration from an early stage, at approximately 3 hours subsequent to the development of the 
infection. Ideally, inflammatory markers in diagnosing the degree of severity in acute cholangitis 
would allow for inexpensive and easy measurement, be highly sensitive and quick, permit diagnosis 
of early stage septicemia, and be correlated with the degree of severity of the infection. It is believed 
that in the diagnosis of the degree of severity in acute cholangitis, PCT could be an inflammatory 
marker that fulfills these requirements.  
These results suggest that acute cholangitis with high PCT levels can signify the need to perform 
emergency biliary drainage and institute intensive care even if categorized by TG13 as not too severe. 
In addition, after the Tokyo guidelines for acute cholangitis and acute cholecystitis will be updated in 
the near future, PCT is expected to play an important role as an inflammatory maker for categorizing 
emergency biliary drainage cases. 
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Figure legends 
Figure 1. Overview of the patients and the study  
 
Figure 2. The relationship between informatory biomarkers and the TG13 severity assessment 
criteria for acute cholangitis. A statistically significant increasing tendency was observed in CRP 
and PCT along with the increase in Grade (CRP: Grade I, 0.4 [0.2-3.5]; Grade II, 3.6 [1.4-7.1]; 
Grade III, 5.4 [2.3-12.0]; *P < 0.001. PCT: Grade I, 0.2 [0.1-0.7]; Grade II, 0.7 0.2-2.7]; Grade III, 
6.8 [0.5-48.3]; **P < 0.001)  
 
Figure 3. Receiver operator characteristic (ROC) curve. (a) ROC curve for the TG13 severity 
assessment criteria grade Ⅲ. Areas under the curve: WBC 0.472 (95% CI: 0.330 to 0.614), CRP 
0.665 (95% CI: 0.543 to 0.786) , PCT 0.748 (95% CI: 0.626 to 0.870) . (b) ROC curve for the 
positive hemoculture at the time of initial diagnosis.  Areas under the curve: WBC 0.53 (95% CI: 
0.37 to 0.69), CRP 0.48 (95% CI: 0.31 to 0.65), PCT 0.80 (95% CI: 0.69 to 0.91). (c) ROC curve 
curve for the findings of purulent bile from the duodenal papilla.  Areas under the curve: WBC 0.51 
(95% CI: 0.37 to 0.66), CRP 0.46 (95% CI: 0.32 to 0.59), PCT 0.77 (95% CI: 0.64 to 0.89).  (d) 
ROC curve for the findings of purulent bile from the duodenal papilla or positive hemoculture into 
mild/moderate cases by theTG13 severity assessment criteria.  Areas under the curve: WBC 0.49 
(95% CI: 0.32 to 0.66), CRP 0.50 (95% CI: 0.34 to 0.65), PCT 0.72 (95% CI: 0.56 to 0.88).  
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Table 1. Relationship with the TG13 severity assessment criteria for acute cholangitis
Age (years) 65.5 [55.8 - 70.5] 80.0 [75.0 - 84.0] 72.0 [66.0 - 82.0] 0 .005 b
Gender (male/female) 14 / 8 30 / 33 16 / 9 0.915 c
WBC (x1000) 7.8 [6.3 - 10.5] 8.7 [6.2 - 12.4] 7.8 [5.1 - 12.9] 0.821 b
CRP 0.4 [0.2 - 3.5] 3.6 [1.4 - 7.1] 5.4 [2.3 - 12.0] <0.001 b
PCT 0.2 [0.1 - 0.7] 0.7 [0.2 - 2.7] 6.8 [0.5 - 48.3] <0.001 b
Serum total bilirubin level (mg/dl) 2.2 [0.9 - 3.5] 2.9 [1.5 - 5.2] 3.3 [1.8 - 4.8] 0 .047 b
AST 188 [137 - 415] 210 [129 - 407] 241 [76 - 529] 0.917 b
ALT 219 [134 - 409] 188 [90 - 413] 237 [78 - 301] 0.329 b
ALP 627 [400 - 1234] 640 [489 - 932] 511 [388 - 698] 0.102 b
γ-GTP 464 [195 - 888] 350 [182 - 588] 240 [94 - 424] 0.009 b
ALB 4.1 ±0.4 3.5 ±0.5 3.1 ±0.7 <0.001 a
BUN 13 [11 - 16] 14 [11 - 19] 20 [15 - 26] 0.002 b
Cr 0.8 [0.6 - 0.9] 0.9 [0.6 - 1.0] 0.9 [0.8 - 1.4] 0 .016 b
PT-INR 1.1 [1.0 - 1.1] 1.1 [1.1 - 1.2] 1.4 [1.1 - 1.7] <0.001 b
PLT 20 [17 - 23] 19 [14 - 23] 10 [9 - 16] <0.001 b
BT 36.8 [36.4 - 37.2] 37.1 [36.5 - 38.4] 38.3 [37.2 - 39.0] <0.001 b
systolic blood pressure (mmHg) 120 ±14 128 ±24 112 ±28 0.259 a
diastolic blood pressure (mmHg) 74 ±14 71 ±15 61 ±11 0.002 a
Pulse 71 [64 - 82] 78 [68 - 87] 82 [75 - 90] 0.022 b
SPO2/FIO2 429 [429 - 476] 429 [381 - 476] 429 [381 - 476] 0.119 b
Disturbance of consciousness (n, %) 0 , 0.0 0 , 0.0 1 , 4.0 0.136 c
the mean±SD; median[IQR]; n, %.
P-value：a, Liner contrast in ANOVA; b, Jonckheere-Terpstra test; c, Cochran-Armitage test.
P-value
Grade I Grade II Grade III
(n = 22) (n = 63) (n = 25)
Table 1
Table 2. Relation with the result of hemoculture at the time of initial diagnosis
Age (years) 76.0 [65.0 - 81.0] 80.0 [64.5 - 86.5] 0.505 b
Gender (male/female) 31 / 28 7 / 6 0.999 c
WBC (X1000) 9.0 [6.5 - 12.5] 11.4 [6.8 - 12.8] 0.747 b
CRP 4.2 [1.2 - 8.5] 2.9 [1.3 - 7.5] 0.792 b
PCT 0.7 [0.2 - 5.6] 8.6 [3.2 - 32.1] 0 .001 b
Serum total bilirubin level (mg/dl) 3.3 [1.5 - 4.4] 1.8 [0.8 - 3.4] 0.062 b
AST 186 [115 - 366] 376 [175 - 597] 0.060 b
ALT 200 [89 -376] 214 [114 - 339] 0.918 b
ALP 643 [490 - 927] 548 [397 - 969] 0.460 b
γ-GTP 338 [185 - 608] 240 [90 - 336] 0.101 b
ALB 3.4 ±0.6 3.4 ±0.7 0.983 a
BUN 16 [12 - 20] 14 [9 - 22] 0.326 b
Cr 0.9 [0.7 - 1.0] 0.6 [0.5 - 1.1] 0.279 b
PT-INR 1.1 [1.0 - 1.3] 1.3 [1.1 - 1.4] 0.212 b
PLT 19 [13 - 22] 15 [11 - 21] 0.257 b
BT 37.1 [36.6 - 38.6] 38.2 [37.6 - 39.1] 0 .018 b
systolic blood pressure (mmHg) 122 ±25 108 ±28 0.071 a
diastolic blood pressure (mmHg) 70 ±15 61 ±17 0.053 a
Pluse 80 [69 - 88] 103 [64 - 122] 0.160 b
SPO2/FiO2 429 [381 - 476] 419 [381 - 432] 0.555 b
Disturbance of consciousness (n, %) 1 , 1.7 0 , 0.0 0.999 c
Grade (n, %) 0.037 b
 I 13 , 22.0 1 , 7.7
 II 35 , 59.3 6 , 46.2
 III 11 , 18.6 6 , 46.2
the mean±SD; median[IQR]; n, %.
P-value：a, Independent t-test; b, Mann-Whitney U test; c, Fisher's exact test.
Negative Positive
(n = 59) (n = 13)
P-value
Table 2
Table 3. Relationship with the findings of bile juice from the duodenal papilla
Age (years) 76.0 [66.0 - 81.0] 77.5 [63.3 - 84.3] 0.733 b
Gender (male/female) 25 / 23 13 / 11 0.999 c
WBC (X1000) 9.3 [6.6 - 12.5] 8.9 [6.8 - 13.1] 0.853 b
CRP 4.6 [0.9 - 9.0] 2.9 [1.5 - 6.3] 0.534 b
PCT 0.6 [0.2 - 2.9] 7.9 [1.2 - 37.7] <0.001 b
Serum total bilirubin level (mg/dl) 2.8 [1.2 - 4.1] 3.5 [1.5 - 5.2] 0.285 b
AST 183 [116 - 348] 304 [148 - 649] 0.045 b
ALT 185 [90 - 355] 237 [116 - 359] 0.327 b
ALP 640 [512 - 967] 615 [416 - 883] 0.293 b
γ-GTP 281 [178 - 558] 330 [191 - 658] 0.496 b
ALB 3.5 ±0.6 3.4 ±0.6 0.654 a
BUN 16 [11 - 23] 15 [11 - 20] 0.484 b
Cr 0.9 [0.6 - 1.1] 0.9 [0.6 - 1.0] 0.536 b
PT-INR 1.1 [1.0 - 1.2] 1.3 [1.1 - 1.4] 0 .034 b
PLT 19 [13 - 23] 15 [11 - 21] 0.147 b
BT 37.2 [36.6 - 38.4] 38.1 [36.8 - 39.0] 0.148 b
systolic blood pressure (mmHg) 121 ±24 118 ±29 0.696 a
diastolic blood pressure (mmHg) 69 ±13 69 ±19 0.979 a
Pulse 78 [66 - 90] 87 [76 - 98] 0.034 b
SPO2/FiO2 429 [383 - 476] 407 [361 - 429] 0.062 b
Disturbance of consciousness (n, %) 1 , 2.1 0 , 0.0 0.999 c
Grade (n, %) 0.007 b
 I 11 , 22.9 3 , 12.5
 II 31 , 64.6 10 , 41.7
 III 6 , 12.5 11 , 45.8
the mean±SD; median[IQR]; n, %.
P-value：a, Independent t-test; b, Mann-Whitney U test; c, Fisher's exact test.
Normal Purulent bile
(n = 48) (n = 24)
P-value
Table 3
Table 4. Investigation into mild/moderate cases by theTG13 severity assessment criteria for acute cholangitis
Age (years) 77.0 [65.0 - 80.0] 78.0 [62.3 - 84.3] 0.604 b
Gender (male/female) 19 / 20 9 / 7 0.768 c
WBC (X1000) 9.1 [6.4 - 12.4] 8.8 [6.4 - 12.0] 0.889 b
CRP 4.5 [0.5 - 9.2] 4.2 [1.7 - 7.4] 0.978 b
PCT 0.4 [0.1 - 1.0] 1.8 [0.4 - 12.3] 0 .012 b
Serum total bilirubin level (mg/dl) 3.1 [1.5 - 4.1] 2.9 [1.7 - 4.3] 0.993 b
AST 186 [119 - 322] 286 [151 - 649] 0.078 b
ALT 181 [87 - 382] 190 [114 - 598] 0.610 b
ALP 639 [511 - 955] 683 [455 - 949] 0.948 b
γ-GTP 291 [182 - 583] 312 [95 - 591] 0.623 b
ALB 3.5 ±0.7 3.3 ±0.4 0.438 a
BUN 16 [11 - 20] 15 [10 - 20] 0.528 b
Cr 0.9 [0.7 - 1.1] 0.8 [0.5 - 1.1] 0.324 b
PT-INR 1.1 [1.0 - 1.2] 1.2 [1.0 - 1.3] 0.421 b
PLT 20 [16 - 27] 19 [16 - 23] 0.697 b
BT 37.0 [36.6 - 38.0] 37.4 [36.6 - 39.0] 0.320 b
systolic blood pressure (mmHg) 124 ±23 134 ±21 0.176 a
diastolic blood pressure (mmHg) 70 ±13 79 ±19 0.074 a
Pulse 78 [67 - 90] 81 [68 - 91] 0.889 b
SPO2/FiO2 429 [387 - 476] 400 [381 - 429] 0.109 b
Disturbance of consciousness (n, %) 1 , 2.1 0 , 0.0 0.999 c
Grade (n, %) 0.734 c
 I 11 , 22.9 3 , 12.5
 II 28 , 58.3 13 , 54.2
 III - , - - , -
the mean±SD; median[IQR]; n, %.
P-value：a, Independent t-test; b, Mann-Whitney U test; c, Fisher's exact test.
Normal bile and
negative hemoculture
 Purulent bile or
positive hemoculture
(n = 39) (n = 16)
P-value
Table 4
110 patients treated for acute cholangitis were based on the TG13 
72 patients, a hemoculture was performed at the time of initial diagnosis 
55 patients, classification into Grade I or Grade II 
Hemoculture (N = 72) 
Positive (N = 59) 
  Grade I   : 13 
  Grade II  : 35  
  Grade III : 11  
Negative (N = 13) 
  Grade I   : 1 
  Grade II  : 6  
  Grade III : 6  
The findings of bile juice (N = 72) 
Normal (N = 48) 
  Grade I   : 11 
  Grade II  : 31  
  Grade III :   6  
Purulent (N = 24) 
  Grade I   :   3 
  Grade II  : 10  
  Grade III : 11  
  Grade I   : 22 
  Grade II  : 63  
  Grade III : 25  
Negative hemoculture and normal bile   : 39 
Positive hemoculture or purulent bile    : 16  
Figure 1 
17 patients, classification into Grade III  
Negative hemoculture and normal bile   :  4 
Positive hemoculture or purulent bile    : 13  
Figure 1
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